Business Wire

St. Jude Medical Announces FDA Approval of the Proclaim Elite SCS System, a Patient-Centric, Recharge-Free, Upgradeable and MR-conditional Chronic Pain Treatment Option

“The approval of the Proclaim Elite recharge-free SCS system is a needed advancement for both patients and physicians who now have access to a low-maintenance chronic pain treatment that can reduce ...
Business Wire

St. Jude Medical Receives CE Mark Approval for Full Body MR Conditional Labeling for the Proclaim Elite Spinal Cord Stimulation System

New labeling ensures patients in need of future MRIs can have full access to the recharge-free Proclaim Elite SCS System and the company’s innovative BurstDR stimulation technology ST. PAUL, ...
Nasdaq

Abbott's (ABT) Proclaim XR SCS Gets FDA Nod for New MRI Label

Abbott Laboratories ABT recently received a new FDA approval with its Proclaim XR spinal cord stimulation system (SCS) for people with chronic pain. This time the regulatory body has approved an ...
Nasdaq

Abbott : FDA Approves Expanded MRI Compatibility For Proclaim XR SCS System With Octrode Leads

(RTTNews) - Abbott (ABT) said that the U.S. Food and Drug Administration has approved new expanded magnetic resonance imaging or MRI compatibility for its Proclaim XR Spinal Cord Stimulation (SCS) ...
Monthly Prescribing Reference

Abbott’s SCS System Cleared for Patients With Painful Diabetic Peripheral Neuropathy

It was originally approved in 2019 for the treatment of chronic pain. The Food and Drug Administration (FDA) has approved the Proclaim™ XR spinal cord stimulation (SCS) system for the treatment of ...
Business Insider

FDA Approves Abbott's Spinal Cord Stimulation for People Living with Painful Diabetic Peripheral Neuropathy

The new indication for Abbott's Proclaim™ XR SCS system provides a non-medication option for people with painful diabetic peripheral neuropathy Spinal cord stimulation is proven to be more effective ...
Monthly Prescribing Reference

Abbott’s Next Generation SCS System Provides Broader Pain Coverage

Credit: Shutterstock. FlexBurst360 therapy provides pain coverage across up to 6 areas of the trunk and/or limbs and enables adjustable programming. The Food and Drug Administration (FDA) has approved ...
Medscape

FDA Lifts Restrictions on Spinal Cord Stimulation System

The US Food and Drug Administration (FDA) has approved updated labeling that expands MRI compatibility for Abbot’s Proclaim XR spinal cord stimulation (SCS) system, the company announced. The FDA ...
Healio

FDA approves spinal cord stimulation system for diabetic pain

Please provide your email address to receive an email when new articles are posted on . The FDA has approved the Proclaim XR spinal cord stimulation system to treat painful diabetic peripheral ...
WFMZ-TV

Global Spinal Cord Stimulation (SCS) Market 2019-2023: Rise in Adoption of Surgical Robots / Proclaim XR / 7D Surgical System / Attempts by Major Players to Strengthen Presence ...

DUBLIN, Dec. 9, 2019 /PRNewswire/ -- The "Global Spinal Cord Stimulation (SCS) Market: Size, Trends & Forecasts (2019-2023)" report has been added to ResearchAndMarkets.com's offering. Global Spinal ...
Medscape

FDA Clears New Neurostimulation System for Chronic Pain

The US Food and Drug Administration (FDA) has approved Abbott Laboratories’ new Proclaim Plus spinal cord stimulation (SCS) system featuring FlexBurst360 therapy for the treatment of patients with ...